Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
about
Concurrent chemoradiotherapy in non-small cell lung cancerThe Role of TLR4 in Chemotherapy-Driven MetastasisModeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumorsSurvival and death signals can predict tumor response to therapy after oncogene inactivationAnalysis of inter-patient variations in tumour growth ratePaclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.Preclinical and pilot clinical studies of docetaxel chemoradiation for Stage III non-small-cell lung cancerTherapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer.DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance.What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.Paracrine control of tissue regeneration and cell proliferation by Caspase-3.Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer.Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinomaPerformance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.Tumor cell senescence response produces aggressive variants.What do we know? Limitations of the two methods most commonly used to estimate the length of the prospective wait.Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.Lung cancer patients in Queensland suffer delays in receiving radiation therapy--but not as a result of distance.Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.Chemotherapy-induced metastasis: mechanisms and translational opportunities.Enhanced cellular functions through induction of LPA2 by cisplatin in fibrosarcoma HT1080 cells.A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.Tumor Size-Dependent Anticancer Efficacy of Chlorin Derivatives for Photodynamic Therapy.mouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
P2860
Q24234963-F6F98A03-CB45-4DDD-AF04-6EDFA70FC6F6Q26861495-0050BD83-88DF-4F62-89D0-CB280F6DA9BEQ27333860-68D26F54-383E-4365-B189-F316E75EDA8EQ30574736-FFD4967B-AC56-49D1-8C60-867096DBAB8CQ33673495-E11F7BFC-FB25-4B95-8F0A-69158E47CCCEQ34290191-F3CF7107-50F1-47B7-B432-B3BBF6DE6CD0Q34462689-7AF614AB-134D-4542-9FA4-098D1A052329Q35706951-C4C6A937-2381-4DFC-9B71-DBD97533ED5BQ35876285-F470BE9E-E43C-4FC3-9603-9F4A2BB94A4BQ35939945-5D3ACCD7-1C4F-4665-B468-6BCB9F199A50Q36710620-D0483E74-F280-4326-99DF-6BEC9FCF5ED2Q36983730-B38F2456-F683-498D-B70E-CBD2E3FA936CQ37085999-8238913B-4012-4D43-96F3-DC6EA5179BC8Q37638983-1365C790-81E7-449E-819E-6EDAA4AF35A6Q38109469-2A4D5928-96CB-4EA9-AF97-7A655B7CDA43Q38120973-EBF77D7D-9423-4955-84D2-5C5605046572Q38139996-B124AC90-39F4-4EE1-B622-02E06E5C963CQ38853138-2DFF82FB-77DD-45A5-8010-21B6BC2BFB50Q40446067-DEB80A37-10A3-4BBF-9A88-F08E36F80A9CQ40557514-D2C84938-F665-4927-A9DA-7B3BD04FE480Q41464237-C71478F7-43FE-4361-A721-5DF66181BEF7Q42610794-F435AB5F-EC1E-4904-91C9-D74520928978Q42659931-C7B40950-4AEE-4E9D-BE4D-980675162BE3Q44840714-860E0CC8-17A8-4959-8CF8-924DC49C953DQ47228068-83B3DF3E-02C4-42AE-B32C-494470AA4D00Q49058675-C046FE63-8125-4C16-A169-FA52D87B998AQ50146851-4CE0D98E-92FD-451E-8731-236D69E4F560Q51002375-8A5645E0-F652-4F5A-B29D-896C09B75A2AQ51664383-DEABCE51-46BA-4630-A041-124137703AA6Q55716591-26F84FD1-6F85-431A-828B-E8AFFACE42DEQ58718463-569DA2DE-0120-4252-99D6-B45A559429FC
P2860
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@ast
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@en
type
label
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@ast
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@en
prefLabel
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@ast
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@en
P2093
P2860
P356
P1476
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.
@en
P2093
J J Battermann
S Y El Sharouni
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601418
P407
P577
2003-12-01T00:00:00Z